Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 2003

View Archived Issues

CHF-3381, a potential new therapy for peripheral painful neuropathies

Squalene synthase inhibitor TAK-475 may have therapeutic potential in dyslipidemia

RWJ-58643, a tryptase inhibitor with potential antiasthmatic activity

JIMB-01, a microtubule-modifying agent, has antiproliferative properties in human malignant tumors

PSA-activated thapsigargin prodrug as a specific agent for prostate cancer

Adenosine A2A receptor antagonist benefits patients with Parkinson's disease

Fluconazole effective in treating early septic shock

Melagatran combined with ximelagatran may be effective in preventing postoperative thromboembolism

New MEK inhibitors and their use patented

GSK scientists present novel 5-HT6 ligands for psychosis, depression, anxiety, etc.

New beta4-selective acetylcholine receptor modulators under study at Lilly

Pyrimidine-based NS5B inhibitors newly discovered by Italian team

New HIV integrase inhibitors in early development at Merck

Novel erythromycin antibiotics designed by Kosan scientists

Daiichi discontinues development of DE-310

New warnings added to Zenapax labeling

Alert issued on Reyataz in combination with Viread

MacroChem expands phase II Topiglan trial into U.S.

FDA grants orphan drug designation for Fidelin

Highlights in psychogeriatrics

New phase I/II trial to evaluate Xcellerated T Cells in treatment of CLL

Once-daily Cipro XR approved for treatment of cUTIs

Nabi submits supplemental data for Nabi-HB Intravenous BLA

Wellbutrin XL approved for major depressive disorder

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...